Disease Overview：Hyperinsulinemia（HI）
Hyperinsulinemia refers to abnormally elevated circulating insulin levels, often resulting from insulin resistance—commonly associated with polycystic ovary syndrome (PCOS), obesity, or metabolic syndrome—and less frequently from congenital hyperinsulinism or insulin-secreting tumors. In reproductive medicine, chronic hyperinsulinemia disrupts gonadotropin secretion, impairs ovarian folliculogenesis, exacerbates androgen excess, and contributes significantly to anovulation, menstrual irregularity, and infertility. Diagnosis involves fasting and post-glucose challenge insulin assays, HOMA-IR calculation, and exclusion of secondary causes such as insulinoma or exogenous insulin use. Management prioritizes lifestyle modification, insulin-sensitizing agents (e.g., metformin), and, when indicated, ovulation induction or assisted reproductive technologies (ART) tailored to metabolic status.
China offers distinct advantages for international patients seeking integrated management of hyperinsulinemia-related infertility. Leading reproductive centers—many accredited by ISO and JCI—employ multidisciplinary teams with deep expertise in metabolic reproductive endocrinology. Advanced diagnostics include dynamic insulin tolerance testing, continuous glucose monitoring integration, and AI-assisted ovarian reserve assessment. Success rates for insulin-resistant PCOS patients undergoing individualized ART protocols exceed 45% per fresh cycle in top-tier hospitals, supported by robust longitudinal outcome data. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising clinical rigor or regulatory compliance. As a dedicated medical tourism agency, we facilitate seamless access: vetting hospitals based on published outcomes and patient safety metrics, providing itemized, transparent pricing in advance, coordinating visa support, arranging interpreters and accommodation, and offering continuity-of-care guidance before, during, and after treatment.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Hyperinsulinemia (Reproductive Medicine Department)
Non-Surgical / Conservative / Medication Options
*Target Criteria:* Insulin resistance confirmed by HOMA-IR ≥2.5, fasting insulin >12 μU/mL, or 2-hr post-OGTT insulin >80 μU/mL; BMI <35 kg/m²; no contraindications to metformin or GLP-1 RAs.
- •Tier 1 (First-Line Lifestyle + Metformin)
- 3-month supervised lifestyle intervention (nutritionist + exercise physiologist visits ×6): $210–$295 - Metformin ER (500 mg × 180 tablets): $18–$24
- •Tier 2 (Add-on GLP-1 RA for BMI ≥28 or failed Tier 1)
- Semaglutide (0.25 mg → 1.0 mg SC weekly × 12 weeks): $385–$470 (brand-name Ozempic® equivalent) - Monthly monitoring (glucose, renal function, CBC): $12 × 12 = $144
Surgical / Procedural / Interventional Options
*Eligibility Criteria:* BMI ≥35 kg/m² *with* documented hyperinsulinemia-induced anovulation/PCOS refractory to ≥6 months of Tier 2 therapy; normal pituitary/adrenal axis; no uncontrolled psychiatric comorbidity.
- •Metabolic Surgery (Sleeve Gastrectomy)
- Laparoscopic sleeve gastrectomy (including anesthesia, 3-day hospital stay, surgeon/anesthesiologist fees): $4,850–$5,620 - 1-year post-op endocrine follow-up (6 visits + labs): $310–$420
Special / Complex Condition Options
- •Severe Congenital Hyperinsulinism (HI) with Reproductive Impact:
- Octreotide infusion (3-month course, outpatient pump): $1,280–$1,540
- •Hyperinsulinemia-Associated Ovarian Hyperstimulation Syndrome (OHSS) Prevention Protocol:
Quick Selection Guide
- •<30 years, BMI <28, mild insulin resistance (HOMA-IR 2.5–4.0): Start with Tier 1 ($310–$420 total). Highest cost-effectiveness for fertility restoration.
- •30–38 years, BMI 28–34, anovulatory PCOS + HOMA-IR >5.0: Proceed directly to Tier 2 ($570–$730 first year). Reduces time-to-conception.
- •≥35 years, BMI ≥35, failed medical therapy + recurrent pregnancy loss: Refer for surgical evaluation—sleeve gastrectomy yields 78% ovulation resumption within 6 months ($5,100–$6,300 total).
- •Any age with congenital HI or OHSS history: Prioritize specialized protocols—genetic testing + octreotide or OHSS prevention bundle is mandatory before ART.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Hyperinsulinemia Medical Vacation Packages
Curated transparent all-inclusive packages combining Hyperinsulinemia treatment with China top medical destinations:
